Event-Driven Stocks

United Health Products, Inc.

UEECOTC

Healthcare · Orthopedic, Prosthetic & Surgical Appliances & Supplies · NV · SEC filings ↗ · Compare ⊕

View price & chart on Yahoo Finance ↗
Signs2 good2 warning3 severedetails ↓

Financials

SEC XBRL · annual
 FY25FY24FY23FY22FY21FY20
Revenue$0$0$0$37,500$59$643
Operating income−$2.3M−$2.0M−$2.4M−$2.8M−$29.8M−$14.8M
Net income−$2.7M−$2.0M−$2.6M−$1.7M−$30.5M−$15.7M
Total assets$316,698$269,979$284,643$350,528$26,799$217,100
Total liabilities$4.2M$2.7M$2.0M$2.4M$1.2M$1.2M
Equity−$3.9M−$2.4M−$1.7M−$2.1M−$1.1M−$953,262
EPS (diluted)$-0.01$-0.01$-0.01
Shares out.252.4M246.8M234.3M228.8M224.0M180.1M

Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.

Key ratios

from filings · FY2025
Operating margin
Net margin
Return on equity
68.9%
Return on assets
−842.9%
Return on capital (ROCE)
Liabilities / assets
1324.0%
Debt / equity
Book value / share
$-0.02
Revenue growth (YoY)
Net income growth (YoY)

Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.

Financial health

forensic scores · FY2025
Altman Z″ (distress)
-965.93distress
Accruals / assets
468.1%clean
Piotroski F-Score
1/8weak

Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.

Quality score

EDS Score
54
/ 100
Profitability 50Growth n/aCatalyst 100Earnings quality 67Financial strength 0

Our own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.

Signs

3 severe2 warning2 good
  • Negative shareholder equity
  • Altman Z″ in the distress zone
  • Filed a late-filing notice (Form NT) — missed an SEC deadline
  • High leverage (liabilities > 70% of assets)
  • Negative operating cash flow
  • Strong return on equity (>15%)
  • Clean earnings (low accruals)

Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.

Risk flags

late SEC filings

A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.

5%+ owners

SEC Schedule 13D / 13G · last 3 yrs

Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.

Insider transactions

SEC Form 4 · most recent
7 acquisitions3 disposals3 open-market buy(s)net +687,275 shares · last 10
InsiderDateTypeSharesPrice
Thom Brian DavidOfficer — Chief Executive OfficerApr 8, 2025Buy32,000$0.24
Thom Brian DavidOfficer — Chief Executive OfficerMar 31, 2025Buy18,000$0.26
Thom Brian DavidOfficer — Chief Executive OfficerMay 12, 2023Sell300,000$0.19
Thom Brian DavidOfficer — Chief Executive OfficerApr 17, 2023Grant309,375$0.22
Thom Brian DavidOfficer — Chief Executive OfficerJan 13, 2023Grant225,000$0.27
Thom Brian DavidOfficer — Chief Executive OfficerSep 16, 2022Grant150,000$0.30
Thom Brian DavidOfficer — Chief Executive OfficerJun 2, 2022Sell127,100$0.51
Thom Brian DavidOfficer — Chief Executive OfficerMay 4, 2022Buy300,000$0.42
Thom Brian DavidOfficer — Chief Executive OfficerJan 3, 2022Sell220,000$0.54
Thom Brian DavidOfficer — Chief Executive OfficerNov 22, 2021Option exercise300,000$0.50

Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.

Short interest

FINRA · bi-monthly
SettlementShares shortDays to coverΔ vs prior
Apr 30, 202612,4101.0-28.1%
Apr 15, 202617,2601.0+56.5%
Mar 31, 202611,0311.0+44.5%
Mar 13, 20267,6351.0-80.5%
Feb 27, 202639,1611.0+153.0%

Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.

Material events

SEC Form 8-K · most recent

Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.

Recent SEC filings

All filings ↗

Event-driven situations (2)

Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.